Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 4/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 5/20 | 0.32 |
| ▸ | PPARD | Q03181 | 5/20 | 0.32 |
| ▸ | PPARA | Q07869 | 5/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | TLR2 | O60603 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL297311 | 1.00 | FFAR3 (0.43) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL4833334 | 0.90 | HDAC3 (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL11803515 | 0.86 | CES1 (0.44) | ALDH1A1CES2CES1TSHRAKR1B1 | |
| SCHEMBL11803517 | 0.86 | CES1 (0.44) | ALDH1A1CES2CES1TSHRAKR1B1 | |
| SCHEMBL4342966 | 0.84 | — | — | |
| SCHEMBL28738389 | 0.83 | HDAC3 (0.42) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL10582805 | 0.82 | GPR84 (0.52) | ALDH1A1CES2CES1TSHRAKR1B1 | |
| SCHEMBL31539947 | 0.82 | GPR84 (0.52) | ALDH1A1CES2CES1TSHRAKR1B1 | |
| SCHEMBL15416621 | 0.82 | GPR84 (0.52) | ALDH1A1CES2CES1TSHRAKR1B1 | |
| SCHEMBL15416620 | 0.82 | GPR84 (0.52) | ALDH1A1CES2CES1TSHRAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114424365-A | Cathode for secondary battery and cathode slurry | 广东省皓智科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| US-12458049-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2025-11-04 | — | — | US | disclosed |
| CN-119601811-A | Method and device for recycling battery electrode | 广东省皓智科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119601812-A | Method and device for recycling battery electrode | 广东省皓智科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119108557-A | Method for preparing cathode slurry of secondary battery | 广东省皓智科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2022-10-13 | — | — | US | disclosed |
| CN-112137954-A | Application of nano-silver in preparation of cosmetics or medicines for preventing and removing fox odor, liquid and preparation method thereof | 成都志俊时代科技有限公司 | 2020-12-29 | — | — | CN | disclosed |
| US-20190223481-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2019-07-25 | — | — | US | disclosed |
| US-20060178278-A1 | Process for Preparing an Overbased Detergent | THE LUBRIZOL CORPORATION (US) | 2006-08-10 | — | — | US | disclosed |
| US-20060144824-A1 | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORPORATION (US) | 2006-07-06 | — | — | US | disclosed |
| US-7071105-B2 | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORPORATION (US) | 2006-07-04 | — | — | US | disclosed |
| CN-1742066-A | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORP (US) | 2006-03-01 | — | — | CN | disclosed |
| EP-1601735-A1 | METHOD OF POLISHING A SILICON-CONTAINING DIELECTRIC | Cabot Microelectronics Corporation (US) | 2005-12-07 | — | — | EP | disclosed |
| WO-2005042677-A1 | PROCESS FOR PREPARING AN OVERBASED DETERGENT | THE LUBRIZOL CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2004069947-A1 | METHOD OF POLISHING A SILICON-CONTAINING DIELECTRIC | CABOT MICROELECTRONICS CORPORATION (US) | 2004-08-19 | — | — | WO | disclosed |
| US-20040152309-A1 | Method of polishing a silicon-containing dielectric | CABOT MICROELECTRONICS CORPORATION | 2004-08-05 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458049-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | FFAR3 1281/4885HDAC3 567/4885HDAC1 739/4885 |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | FFAR3 768/4885HDAC3 751/4885HDAC1 1652/4885 |
| US-20220323528-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | SI, TAS2R7, TAS2R31 | FFAR3 1281/4885HDAC3 567/4885HDAC1 739/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | FFAR3 1281/4885HDAC3 567/4885HDAC1 739/4885 |
| US-20060178278-A1 | Process for Preparing an Overbased Detergent | DEGS1, ADH1C, CYP26B1 | FFAR3 304/4885HDAC3 4133/4885HDAC1 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.